Abstract
Ca2+ ions are key second messengers in both excitable and non-excitable cells. Owing to the rather pleiotropic nature of Ca2+ transporters and other Ca2+-binding proteins, however, Ca2+ signaling has attracted limited attention as a potential target of anticancer therapy. Here, we discuss cancer-associated alterations of Ca2+ fluxes at specific organelles as we identify novel candidates for the development of drugs that selectively target Ca2+ signaling in malignant cells.
Original language | English |
---|---|
Pages (from-to) | 1055-1069 |
Number of pages | 15 |
Journal | Molecular Cell |
Volume | 78 |
Issue number | 6 |
DOIs | |
State | Published - Jun 18 2020 |
Externally published | Yes |
Keywords
- IPR
- MCU complex
- mitochondrial permeability transition
- ORAI
- store-operated calcium entry
- TRP channels